Smartphone Dual‐Channel Biosensor for Simultaneous PLGF/sFlt‐1 Detection and Signaling Pathway Analysis
Small · 2025
DOI: 10.1002/smll.202503452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Zetao Chen und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Disaster and Emergency Medicine, Tianjin University, Tianjin, 300072, China. Hauptthemen laut MEDLINE: Biosensing Techniques, Vascular Endothelial Growth Factor Receptor-1, Placenta Growth Factor, Smartphone. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Wenzhou City, National Key Research and Development Project, Science and Technology Planning Project of Wenzhou.
Abstract (Originalsprache)
Preeclampsia in pregnancies affects angiogenesis while the fetus develops. Early diagnosis of preeclampsia can enable timely prognosis and intervention. This study developed a smartphone‐based, label‐free dual‐channel electrochemical biosensing platform for the simultaneous detection of preeclampsia biomarkers, placental growth factor (PLGF) and soluble Fms‐like tyrosine kinase‐1 (sFlt‐1). Based on the functional modification of gold nanoparticles and reduced graphene oxide on working electrodes, the specific surface area is enlarged, and the stability is improved. PLGF and sFlt‐1 antibody serving as sensitive elements, are immobilized on the electrode surface. As PLGF binds sFlt‐1 dynamically, fluidic chambers are designed based on 3D printing for comprehensive detection. The biosensor achieved linear ranges of 10–8000 pg mL −1 for sFlt‐1 and 1–250 pg mL −1 for PLGF, meeting clinical diagnostic requirements. Molecular docking is used to analyze the binding properties and signaling pathways of PLGF and sFlt‐1, providing critical diagnostic insights for clinicians. This biosensing platform, featuring a portable integrated circuit and smartphone‐based APP, enables point‐of‐care testing (POCT). Comparison tests using plasma samples from 10 individuals demonstrated a strong correlation (r > 0.98, p > 0.1) with ELISA, indicating the potential in clinical POCT applications for preeclampsia. These results suggest that the sensor can be used as a dual‐channel biomarker for preeclampsia without sample labeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Disaster and Emergency Medicine, Tianjin University, Tianjin, 300072, China.
- Wenzhou Safety (Emergency) Institute, Tianjin University, Wenzhou, 325000, China.
- Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin, 300072, China.
- Department of Obstetrics and Gynecology, the Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, 325035, China.
- The Third Affiliated Hospital of Shanghai University, Shanghai, 201999, China.
- Wenzhou People's Hospital, Wenzhou Maternal and Child Health Care Hospital, Wenzhou, 325000, China.
ORCID-Profile: Liqiong Guo
Förderung
- Natural Science Foundation of Wenzhou City
- National Key Research and Development Project
- Science and Technology Planning Project of Wenzhou
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chen, Z., Li, W., Li, C., Huang, S., He, Y., Duan, L., Luo, H., Zheng, J., Zhang, H., Li, C., Han, C., Chen, B., Lin, Z., Li, S., Li, P., Deng, F., Hou, S., & Guo, L. (2025). Smartphone Dual‐Channel Biosensor for Simultaneous PLGF/sFlt‐1 Detection and Signaling Pathway Analysis. Small. https://doi.org/10.1002/smll.202503452
Vancouver
Chen Z, Li W, Li C, Huang S, He Y, Duan L, et al. Smartphone Dual‐Channel Biosensor for Simultaneous PLGF/sFlt‐1 Detection and Signaling Pathway Analysis. Small. 2025. doi:10.1002/smll.202503452
BibTeX
@article{Chen2025,
author = {Chen, Zetao and Li, Weixia and Li, Chuanlong and Huang, Songsong and He, Yuhong and Duan, Liyang and Luo, Hui and Zheng, Jianqiong and Zhang, Hongping and Li, Chen and Han, Cha and Chen, Bin and Lin, Zi and Li, Shuang and Li, Penghui and Deng, Furong and Hou, Shike and Guo, Liqiong},
title = {Smartphone Dual‐Channel Biosensor for Simultaneous PLGF/sFlt‐1 Detection and Signaling Pathway Analysis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202503452}
}
EUVIMED